Literature DB >> 19088353

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Bethany B Barone1, Hsin-Chieh Yeh, Claire F Snyder, Kimberly S Peairs, Kelly B Stein, Rachel L Derr, Antonio C Wolff, Frederick L Brancati.   

Abstract

CONTEXT: Diabetes mellitus appears to be a risk factor for some cancers, but the effect of preexisting diabetes on all-cause mortality in newly diagnosed cancer patients is less clear.
OBJECTIVE: To perform a systematic review and meta-analysis comparing overall survival in cancer patients with and without preexisting diabetes. DATA SOURCES: We searched MEDLINE and EMBASE through May 15, 2008, including references of qualifying articles. STUDY SELECTION: English-language, original investigations in humans with at least 3 months of follow-up were included. Titles, abstracts, and articles were reviewed by at least 2 independent readers. Of 7858 titles identified in our original search, 48 articles met our criteria. DATA EXTRACTION: One reviewer performed a full abstraction and other reviewers verified accuracy. We contacted authors and obtained additional information for 3 articles with insufficient reported data.
RESULTS: Studies reporting cumulative survival rates were summarized qualitatively. Studies reporting Cox proportional hazard ratios (HRs) or Poisson relative risks were combined in a meta-analysis. A random-effects model meta-analysis of 23 articles showed that diabetes was associated with an increased mortality HR of 1.41 (95% confidence interval [CI], 1.28-1.55) compared with normoglycemic individuals across all cancer types. Subgroup analyses by type of cancer showed increased risk for cancers of the endometrium (HR, 1.76; 95% CI, 1.34-2.31), breast (HR, 1.61; 95% CI, 1.46-1.78), and colorectum (HR, 1.32; 95% CI, 1.24-1.41).
CONCLUSIONS: Patients diagnosed with cancer who have preexisting diabetes are at increased risk for long-term, all-cause mortality compared with those without diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 19088353      PMCID: PMC3093051          DOI: 10.1001/jama.2008.824

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  87 in total

1.  Colorectal cancer: another complication of diabetes mellitus?

Authors:  J C Will; D A Galuska; F Vinicor; E E Calle
Journal:  Am J Epidemiol       Date:  1998-05-01       Impact factor: 4.897

2.  The influence of gender on incidence and outcome of patients with bladder cancer in Harlem.

Authors:  G P Hoke; B A Stone; L Klein; K N Williams
Journal:  J Natl Med Assoc       Date:  1999-03       Impact factor: 1.798

3.  Comorbidity as a predictor of stage of illness for patients with breast cancer.

Authors:  Steven T Fleming; Holly G Pursley; Beth Newman; Dmitri Pavlov; Kun Chen
Journal:  Med Care       Date:  2005-02       Impact factor: 2.983

4.  The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study.

Authors:  H A A M Maas; R F P M Kruitwagen; V E P P Lemmens; S H Goey; M L G Janssen-Heijnen
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

5.  Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study.

Authors:  F Ederer; M S Geisser; S J Mongin; T R Church; J S Mandel
Journal:  J Clin Epidemiol       Date:  1999-05       Impact factor: 6.437

6.  Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.

Authors:  Ales Tomazic; Vladislav Pegan; Ksaverija Ferlan-Marolt; Alojz Pleskovic; Bostjan Luzar
Journal:  Hepatogastroenterology       Date:  2004 Nov-Dec

7.  Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection.

Authors:  Y Ikeda; M Shimada; H Hasegawa; T Gion; K Kajiyama; K Shirabe; K Yanaga; K Takenaka; K Sugimachi
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

8.  Survival after resection for ductal adenocarcinoma of the pancreas.

Authors:  C Sperti; C Pasquali; A Piccoli; S Pedrazzoli
Journal:  Br J Surg       Date:  1996-05       Impact factor: 6.939

9.  Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: a preliminary study.

Authors:  K Tanisada; T Teshima; H Ikeda; M Abe; T Yamashita; M Nishio; T Inoue; M Hiraoka; Y Hirokawa; M Oguchi; S Yamada; K Sakai; T Nishimura; M Chatani
Journal:  Radiat Med       Date:  1998 Nov-Dec

10.  Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.

Authors:  N Nagasue; H Kohno; M Tachibana; A Yamanoi; H Ohmori; O N El-Assal
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

View more
  321 in total

Review 1.  Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Authors:  Ying Jiang; Qiwen Ben; Hong Shen; Weiqi Lu; Yong Zhang; Jun Zhu
Journal:  Eur J Epidemiol       Date:  2011-09-22       Impact factor: 8.082

2.  Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.

Authors:  Robert M Cannon; Ryan LeGrand; Ryaz B Chagpar; Syed A Ahmad; Rebecca McClaine; Hong Jin Kim; Christopher Rupp; Cliff S Cho; Adam Brinkman; Sharon Weber; Emily R Winslow; David A Kooby; Carrie K Chu; Charles A Staley; Ian Glenn; William G Hawkins; Alexander A Parikh; Nipun B Merchant; Kelly M McMasters; Robert C G Martin; Glenda G Callender; Charles R Scoggins
Journal:  HPB (Oxford)       Date:  2012-01-19       Impact factor: 3.647

3.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

4.  Cancer and diabetes: are we ready for prime time?

Authors:  U Smith; E A M Gale
Journal:  Diabetologia       Date:  2010-06-13       Impact factor: 10.122

5.  The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer.

Authors:  Elizabeth Y Chiao; Preethi V Nambi; Aanand D Naik
Journal:  J Cancer Surviv       Date:  2010-08-19       Impact factor: 4.442

6.  New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.

Authors:  Donghui Li; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

Review 7.  The epidemiology of diabetes and cancer.

Authors:  Bendix Carstensen; Marit Eika Jørgensen; Søren Friis
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

8.  Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

Authors:  Jacqueline Neuhaus; Brian Angus; Justyna D Kowalska; Alberto La Rosa; Jim Sampson; Deborah Wentworth; Amanda Mocroft
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

9.  Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation.

Authors:  Sejeong Shin; Laura Wolgamott; Yonghao Yu; John Blenis; Sang-Oh Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

10.  Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

Authors:  Rebecca A Shelby; Caroline S Dorfman; Sarah S Arthur; Hayden B Bosworth; Leonor Corsino; Linda Sutton; Lynda Owen; Alaattin Erkanli; Francis Keefe; Cheyenne Corbett; Gretchen Kimmick
Journal:  Contemp Clin Trials       Date:  2020-04-11       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.